Ramiro Guerrero - 03 Mar 2025 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Ramiro Guerrero
Issuer symbol
MAIA
Transactions as of
03 Mar 2025
Net transactions value
+$111,666
Form type
4
Filing time
05 Mar 2025, 16:42:20 UTC
Previous filing
05 Mar 2025
Next filing
08 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MAIA Common Stock Purchase $50,000 +33,333 +6.2% $1.50 568,218 03 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Warrants Purchase $61,666 +33,333 $1.85 33,333 03 Mar 2025 Common Stock 33,333 $1.85 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on March 3, 2025.
F2 These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on March 3, 2025. The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date.